Aspirin "resistance"

Blood Cells, Molecules, and Diseases

Volumn 36, Issue 2, 2006, Pages 171-176

  Schrör, Karsten ^a   Weber, Artur Aron ^a   Hohlfeld, Thomas ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Aspirin resistance; Myocardial infarction; Platelet function; Stroke; Thromboxane

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2; THROMBOXANE;

ARTICLE; CORONARY ARTERY BYPASS SURGERY; DNA POLYMORPHISM; DRUG RESISTANCE; EX VIVO STUDY; HUMAN; IMMUNOREACTIVITY; IN VITRO STUDY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE FUNCTION;

ASPIRIN; BLOOD PLATELETS; CYCLOOXYGENASE 2; DRUG RESISTANCE; HUMANS; ISOENZYMES; MEMBRANE PROTEINS;

EID: 33645319021     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2005.12.017     Document Type: Article

References (40)

1. A.A. Weber, B. Przytulski, and A. Schanz Towards a definition of aspirin resistance: a typological approach Platelets 13 2002 37
2. D. Mukherjee, and E.J. Topol Pharmacogenomics in cardiovascular diseases Prog. Cardiovasc. Dis. 44 2002 479
3. M. Cattaneo Aspirin and clopidogrel. Efficacy, safety, and the issue of drug resistance Arterioscler. Thromb. Vasc. Biol. 24 2004 1980
4. S.A. McKee, D.C. Sane, and E.N. Deliargyris Aspirin resistance in cardiovascular disease: a review of prevalence, mechanisms, and clinical significance Thromb. Haemost. 88 2002 711
5. P.J. Mason, A.K. Jacobs, and J.E. Freedman Aspirin resistance and atherothrombotic disease J. Am. Coll. Cardiol. 46 2005 986
6. C.H. Hennekens, K. Schrör, S. Weisman, and G.A. FitzGerald Terms and conditions. Semantic complexicity and aspirin resistance Circulation 110 2004 1706
7. S. Sanderson, J. Emery, T. Baglin, and A.L. Kinmonth Narrative review: aspirin resistance and its clinical implications Ann. Intern. Med. 142 2005 370
8. M. Vejar, G. Fragasso, and D. Hackett Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina Thromb. Haemost. 63 1990 163
9. I.C.H. Benedek, A.S. Joshi, and H.J. Pieniaszek Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers J. Clin. Pharmacol. 35 1995 1181
10. M.R. Buchanan, and S.J. Brister Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinically J. Can. Cardiol. 11 1995 221
11. H. Tohgi, S. Konno, and K. Tamura The effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin Stroke 23 1992 1400
12. C.M. Helgason, K.M. Bolin, and J.A. Hoff Development of aspirin resistance in persons with previous ischemic stroke Stroke 25 1994 2331
13. M.R. Mueller, A. Salat, and P. Stangl Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty Thromb. Haemost. 78 1997 1003
14. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients Br. J. Med. 324 2002 71
15. K. Schrör Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis Semin. Thromb. Hemost. 23 1997 349
16. I.A.G. Reilly, and G.A. FitzGerald Inhibition of thromboxane formation in vivo and ex vivo Blood 69 1987 180
17. 2 for their receptor are similar in washed human platelets Biochem. Biophys. Acta 157 1988 733
18. G. De Gaetano, and C. Cerletti Aspirin resistance: a revival of platelet aggregation tests? J. Thromb. Haemost. 1 2003 2048
19. D.L. Bhatt, and E.J. Topol Scientific and therapeutic advances in antiplatelet therapy Nat. Rev., Drug Discov. 2 2003 15
20. P.A. Gum, K. Kottke-Marchant, and E.D. Poggio Profile and prevalence of aspirin resistance in patients with cardiovascular disease J. Am. Cardiol. 88 2001 230
21. N. Zimmermann, A. Wenk, and U. Kim Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery Circulation 108 2003 542
22. 2 formation in the human circulation Proc. Natl. Acad. Sci. U. S. A. 83 1986 5861
23. G. Montalescot, J. Maclouf, and G. Drobinski Eicosanoid biosynthesis in patients with stable angina: beneficial effects of very low dose aspirin J. Am. Coll. Cardiol. 24 1994 33
24. F. Cipollone, G. Ciabattoni, and P. Patrignani Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina Circulation 102 2000 1007
25. J.W. Eikelboom, J. Hirsh, and J.I. Weitz Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke or cardiovascular death in patients at high risk for cardiovascular events Circulation 105 2002 1650
26. K.A. Schwartz, D.E. Schwartz, and E. Ghosheh Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction J. Am. Cardiol. 95 2005 973
27. F. Catella-Lawson, M.P. Reilly, and S.C. Kapoor Cyclooxygenase inhibitors and the antiplatelet effect of aspirin N. Engl. J. Med. 345 2001 1809
28. G.H. Rao, G.G. Johnson, K.R. Reddy, and J.G. White Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin Arteriosclerosis 3 1983 383
29. G.A. FitzGerald Parsing an enigma: the pharmacodynamics of aspirin resistance Lancet 361 2003 542
30. A.A. Weber, K.C. Zimmermann, J. Meyer-Kirchrath, and K. Schrör Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance Lancet 353 1999 900
31. P. Censarek, K. Freidel, M. Udelhoven, and S.-J. Ku Cyclooxygenase COX-2a, a novel COX-2 mRNA variant, in platelets from patients after coronary artery bypass grafting Thromb. Haemost. 92 2004 925
32. E. Lim, Z. Ali, and A. Ali Indirect comparison meta-analysis of aspirin therapy after coronary surgery Br. J. Med 327 2003 1309
33. P.Y. Lee, W.H. Chen, and W. Ng Low-dose aspirin increases aspirin resistance in patients with coronary artery disease Am. J. Med. 118 2005 723
34. L.P. Audoly, B. Rocca, and J.E. Fabre Cardiovascular responses to the isoprostanes iPF (2α)-III and iPE (2)-III are mediated via the thromboxane A (2) receptor in vivo Circulation 101 2000 2833
35. E. Vericel, C. Januel, and M. Carreras Diabetic patients without vascular complications display enhanced basal platelet activation and decreased antioxidant status Diabetes 53 2004 1046
36. J.A. Cambria-Kiely, and P.J. Gandhi Aspirin resistance and genetic polymorphism J. Thromb. Thrombolysis 14 2002 51
37. M.K. Halushka, M.P. Walker, and P.V. Halushka Genetic variation in cyclooxygenase 1: effects on response to aspirin Clin. Pharmacol. Ther. 73 2003 122
38. W.H. Chen, P.Y. Lee, and W. Ng Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment J. Am. Coll. Cardiol. 43 2004 1122
39. P.A. Gum, K. Kottke-Marchant, and P.A. Welsh A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease J. Am. Coll. Cardiol. 41 2003 961
40. J.C. Wang, D. Aucoin, and D. Manuelian Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA J. Am. Cardiol. 92 2003 1492